Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of RFUS-949 tablets for postoperative pain after abdominal surgery
CTR20263049Phase 2Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute postoperative pain comparing RFUS-949 with Placebo (2 arms). Primary endpoints: SPID48 at rest and during movement, SPID6, SPID12, SPID24, SPID36 at rest and during movement and 8 more. Started Sep 2026; status: active.
02
Drugs
RFUS-949
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on CTR20263049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263049.